EUVIMEDEUVIMED entdecken
ÄquivalenzstudieRandomisierte kontrollierte Studie

Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial

Vaishakh Anand iD, Sheffali Gulati iD, Anuja Agarwala, Gautam Kamila iD, Aakash Mahesan iD, Vishal Sondhi iD, Kanak L Gupta, Biswaroop Chakrabarty iD, Prashant Jauhari iD, Prateek Kumar Panda iD, Ravindra Mohan Pandey

Epilepsia · 2025

DOI: 10.1111/epi.18292 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Epilepsia, 2025. Verfasst von Vaishakh Anand und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence & Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India In…. Hauptthemen laut MEDLINE: Diet, High-Protein Low-Carbohydrate, Diet, Ketogenic, Drug Resistant Epilepsy, Glycemic Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The ketogenic diet has been the mainstay of treatment of drug‐resistant epilepsy (DRE). No comparative trials have been conducted to assess the efficacy of the two less strict ketogenic diets: modified Atkins diet (MAD) and low glycemic index treatment (LGIT). This study assesses the non‐inferiority of LGIT compared with MAD.

Methods

This was an open‐label randomized non‐inferiority trial. Children with DRE were randomized to receive either MAD or LGIT as an add‐on to anti‐seizure medications. The primary endpoint was percentage seizure reduction at the end of 24 weeks of therapy compared to the baseline. The non‐inferiority margin of −15% was predefined to calculate the sample size.

Results

Ninety‐one children were enrolled and randomized to receive either MAD ( n = 45) or LGIT ( n = 46). Intention‐to‐treat analysis done at the end of 24 weeks of therapy showed a mean (±standard deviation [SD]) percentage seizure reduction of 60.7% (±41.3) in the MAD sub‐group and 57% (±39.4) in the LGIT sub‐group ( p = 0.664). The absolute difference between the means of percentage seizure reduction was −3.7 (−20.5 to 13.2) and crossed the non‐inferiority margin. Ten children in the MAD group and nine children in the LGIT group did not complete 24 weeks of therapy. Adverse effects were comparable between the arms (MAD, 66.6%; LGIT, 50%), although serious adverse effects were higher in the MAD arm. The most common adverse effect was decreased acceptance (24.2%) followed by decreased satiety (9.9%), vomiting (9.9%), weight loss (5.5%), constipation (5.5%), and diarrhea (3.3%). Dyslipidemia was more commonly seen in the MAD group (MAD, six; LGIT, one). One death in the LGIT arm was unrelated to therapy. Although there was no statistically significant difference in improvement in cognition, behavior, and quality of life scales, improvement was noted from baseline scores. Significance LGIT may be non‐inferior to MAD in the treatment of children with DRE with the advantage of increased acceptance and fewer adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-Protein Low-CarbohydrateDiet, KetogenicDrug Resistant EpilepsyGlycemic IndexAdolescentChildChild, PreschoolFemaleHumansMaleAnticonvulsantsTreatment Outcome

Stichwörter der Autor:innen

drug resistant epilepsyketogenic dietlow glycemic index treatmentmodified atkins diet

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Centre of Excellence & Advanced Research for Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pediatrics, Senior Dietician, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pediatrics, Armed Forces Medical College, Pune, India.
  • Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Vaishakh Anand, Sheffali Gulati, Gautam Kamila, Aakash Mahesan, Vishal Sondhi, Biswaroop Chakrabarty, Prashant Jauhari, Prateek Kumar Panda

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Anand, V., Gulati, S., Agarwala, A., Kamila, G., Mahesan, A., Sondhi, V., Gupta, K. L., Chakrabarty, B., Jauhari, P., Panda, P. K., & Pandey, R. M. (2025). Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial. Epilepsia. https://doi.org/10.1111/epi.18292

Vancouver

Anand V, Gulati S, Agarwala A, Kamila G, Mahesan A, Sondhi V, et al. Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial. Epilepsia. 2025. doi:10.1111/epi.18292

BibTeX
@article{Anand2025,
  author = {Anand, Vaishakh and Gulati, Sheffali and Agarwala, Anuja and Kamila, Gautam and Mahesan, Aakash and Sondhi, Vishal and Gupta, Kanak L and Chakrabarty, Biswaroop and Jauhari, Prashant and Panda, Prateek Kumar and Pandey, Ravindra Mohan},
  title = {Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug‐resistant epilepsy: A randomized non‐inferiority trial},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18292}
}
Kostenlos starten →